{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:12:32Z","timestamp":1790835152857,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012616","name":"Fondation Schlumberger pour l\u2019Education et la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007492","name":"Fondation Bettencourt Schueller","doi-asserted-by":"publisher","award":["2023"],"award-info":[{"award-number":["2023"]}],"id":[{"id":"10.13039\/501100007492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"University of Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biocel.2024.106669","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T03:01:23Z","timestamp":1727233283000},"page":"106669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Classical psychedelics\u2019 action on brain monoaminergic systems"],"prefix":"10.1016","volume":"176","author":[{"given":"Jasmine Jade","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Aman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-5706","authenticated-orcid":false,"given":"Anna","family":"Beyeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Deurwaerd\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2024.106669_bib1","article-title":"A proposed animal model for hallucinogens based on LSD\u2019s effects on patterns of exploration in rats","author":"Adams","year":"1986","journal-title":"Behav. Neunwcience"},{"key":"10.1016\/j.biocel.2024.106669_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/0006-8993(80)90997-X","article-title":"Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli","volume":"186","author":"Aghajanian","year":"1980","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.161.3842.706","article-title":"Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe","volume":"161","author":"Aghajanian","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.biocel.2024.106669_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cercor\/bhg128","article-title":"Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex","volume":"14","author":"Amarg\u00f3s-Bosch","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biocel.2024.106669_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00165384","article-title":"The 5-HTIA receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons","volume":"347","author":"Arborelius","year":"1993","journal-title":"Naunyn-Schmiede \u2019S. Arch. Pharm."},{"key":"10.1016\/j.biocel.2024.106669_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1471-4159.2010.06848.x","article-title":"The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity","volume":"114","author":"Auclair","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyac075","article-title":"Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants","volume":"26","author":"Becker","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib8","doi-asserted-by":"crossref","unstructured":"Berlyne, D.E., 1966. Curiosity and Exploration 153.","DOI":"10.1126\/science.153.3731.25"},{"key":"10.1016\/j.biocel.2024.106669_bib9","series-title":"in: Progress in Brain Research","first-page":"3","article-title":"Multiple facets of serotonergic modulation","author":"Beyeler","year":"2021"},{"key":"10.1016\/j.biocel.2024.106669_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biocel.2024.106669_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00213-010-1784-0","article-title":"The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen","volume":"209","author":"Canal","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biocel.2024.106669_bib13","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biocel.2024.106669_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2018.09.015","article-title":"Serotonin2B receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons","volume":"311","author":"Cathala","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biocel.2024.106669_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuint.2019.01.019","article-title":"Neurochemical impact of the 5-HT2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain","volume":"124","author":"Chagraoui","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biocel.2024.106669_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0306-4522(93)90262-E","article-title":"A 5-hydroxytryptamine2 agonist augments \u03b3-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons","volume":"54","author":"Chiang","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.biocel.2024.106669_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pneurobio.2016.03.004","article-title":"Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications","volume":"151","author":"De Deurwaerd\u00e8re","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.biocel.2024.106669_bib18","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits In Vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerd\u00e8re","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","article-title":"The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A, D 2 and TAAR 1 receptors","volume":"113","author":"De Gregorio","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biocel.2024.106669_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pharmthera.2017.07.014","article-title":"The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: rationale and current status of research","volume":"181","author":"Devroye","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biocel.2024.106669_bib21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3389\/fphar.2020.00962","article-title":"Lorcaserin alters serotonin and noradrenaline tissue content and their interaction with dopamine in the rat brain","volume":"11","author":"Di Giovanni","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00655-1","article-title":"Selective blockade of serotonin-2C\/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study","volume":"91","author":"Di Giovanni","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.biocel.2024.106669_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2","article-title":"Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C\/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study","volume":"35","author":"Di Giovanni","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.biocel.2024.106669_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00541","article-title":"Monoaminergic and histaminergic strategies and treatments in brain diseases","volume":"10","author":"Di Giovanni","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02246-0","article-title":"Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors","volume":"865","author":"Di Matteo","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib26","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT 1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"D\u00edaz-Mataix","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cne.1147","article-title":"Targeting of serotonin 1a receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain","volume":"433","author":"Doherty","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biocel.2024.106669_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007952","article-title":"Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice","volume":"4","author":"Doly","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2024.106669_bib29","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1523\/JNEUROSCI.1354-17.2017","article-title":"Serotonin 2B receptors in mesoaccumbens dopamine pathway regulate cocaine responses","volume":"37","author":"Doly","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1476-5381.1992.tb14493.x","article-title":"Evidence that 5-HT 2 receptor activation decreases noradrenaline release in rat hippocampus in vivo","volume":"107","author":"Done","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib31","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1242\/dmm.026120","article-title":"Rodent models in neuroscience research: is it a rat race?","volume":"9","author":"Ellenbroek","year":"2016","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.biocel.2024.106669_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bcp.2018.09.024","article-title":"Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: high potency agonists at 5-HT2A receptors","volume":"158","author":"Eshleman","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jnc.12988","article-title":"Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro","volume":"133","author":"Fan","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/syn.21551","article-title":"Involvement of 5-HT 2A receptor and \u03b1 2 -adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow","volume":"66","author":"Fr\u00e5nberg","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.biocel.2024.106669_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(91)90499-G","article-title":"Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT agonist, DOI","volume":"199","author":"Garratt","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0028-3908(98)00188-9","article-title":"Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats","volume":"38","author":"Gobert","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.biocel.2024.106669_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.biocel.2024.106669_bib39","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biocel.2024.106669_bib40","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0028-3908(91)90028-A","article-title":"Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: involvement of the prepositus hypoglossal nucleus","volume":"30","author":"Gorea","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(73)90206-9","article-title":"Mescaline and LSD: direct and indirect effects on serotonin-containing neurons in brain","volume":"21","author":"Haigler","year":"1973","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib43","series-title":"in: Current Topics in Behavioral Neurosciences","first-page":"159","article-title":"Effect of hallucinogens on unconditioned behavior","author":"Halberstadt","year":"2018"},{"key":"10.1016\/j.biocel.2024.106669_bib44","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/cn400216u","article-title":"Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A\/2C agonists","volume":"5","author":"Hansen","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0304-3940(89)90489-8","article-title":"Serotonergic dorsal raphe neurons: changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration","volume":"103","author":"Heidenreich","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biocel.2024.106669_bib46","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00213-021-05860-5","article-title":"Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe","volume":"238","author":"Herian","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12640-019-00033-x","article-title":"Hallucinogen-like action of the novel designer drug 25I-NBOMe and its effect on cortical neurotransmitters in rats","volume":"36","author":"Herian","year":"2019","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.biocel.2024.106669_bib48","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s43440-020-00181-4","article-title":"Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission","volume":"72","author":"Herian","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biocel.2024.106669_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biocel.2024.106669_bib50","first-page":"1","article-title":"LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up","author":"Holze","year":"2024","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.biocel.2024.106669_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0006-8993(01)02596-3","article-title":"DOI, a 5-HT2A\/2C receptor agonist, attenuates clozapine-induced cortical dopamine release","volume":"907","author":"Ichikawa","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-8993(95)00865-N","article-title":"DOI, a 5-HT2A\/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum","volume":"698","author":"Ichikawa","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13041-020-00605-5","article-title":"Expression of serotonin 1A and 2A receptors in molecular- and projection-defined neurons of the mouse insular cortex","volume":"13","author":"Ju","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.biocel.2024.106669_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(91)90675-G","article-title":"Effects of repeated treatment with 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on the autoregulatory control of dorsal raphe 5-HT neuronal firing and cortical 5-HT release","volume":"200","author":"Kidd","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib55","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1471-4159.2009.06356.x","article-title":"In vivo evidence that constitutive activity of serotonin 2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist","volume":"111","author":"Leggio","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<172::AID-SYN7>3.0.CO;2-9","article-title":"Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: way 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535","volume":"30","author":"Lejeune","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.biocel.2024.106669_bib57","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0024-3205(69)90142-8","article-title":"The effects of some hallucinogenic drugs upon the metabolism of noradrenaline","volume":"8","author":"Leonard","year":"1969","journal-title":"Life Sci."},{"key":"10.1016\/j.biocel.2024.106669_bib58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(02)02620-3","article-title":"5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner","volume":"947","author":"Li\u00e9geois","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib59","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","article-title":"5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","volume":"22","author":"Llado-Pelfort","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biocel.2024.106669_bib60","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0028-3908(99)00193-8","article-title":"The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used","volume":"39","author":"Lucas","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1471-4159.2000.740693.x","article-title":"Role of striatal serotonin 2A and serotonin 2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum","volume":"74","author":"Lucas","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib62","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.biocel.2024.106669_bib63","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin-2a receptors through a glutamate-dependent mechanism","volume":"21","author":"Mart\u0131\u0301n-Ruiz","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib64","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1021\/jm060656o","article-title":"1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists","volume":"49","author":"McLean","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biocel.2024.106669_bib65","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3389\/fphar.2019.01406","article-title":"Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe","volume":"10","author":"Miliano","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib66","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib68","series-title":"in: Progress in Brain Research","first-page":"25","article-title":"The renaissance in psychedelic research: What do preclinical models have to offer","author":"Murnane","year":"2018"},{"key":"10.1016\/j.biocel.2024.106669_bib69","doi-asserted-by":"crossref","unstructured":"Nash, J.F., Brodkin, J., 1991. Microdialysis Studies on 3,4-Methylenedioxymethamphetamine- Induced Dopamine Release: Effect of Dopamine Uptake lnhibitor&. THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 259(2), 820\u2013825.","DOI":"10.1016\/S0022-3565(25)20405-0"},{"key":"10.1016\/j.biocel.2024.106669_bib70","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/0024-3205(90)90484-9","article-title":"Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysis","volume":"47","author":"Nash","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.biocel.2024.106669_bib71","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.npp.1300329","article-title":"In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum","volume":"29","author":"Navailles","year":"2004","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biocel.2024.106669_bib72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biocel.2024.106669_bib73","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF02245008","article-title":"Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function","volume":"112","author":"Palfreyman","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0278-5846(96)00076-0","article-title":"Actions of methoxylated amphetamine hallucinogen on serotonergic neurons of the brain","volume":"20","author":"Penington","year":"1996","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biocel.2024.106669_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1471-4159.1984.tb06681.x","article-title":"Effects of methiothepin and lysergic acid diethylamide on serotonin release In Vitro and serotonin synthesis In Vivo: possible relation to serotonin autoreceptor function","volume":"43","author":"Pettibone","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/272278a0","article-title":"Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis","volume":"272","author":"Pieri","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2024.106669_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","article-title":"5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum","volume":"26","author":"Porras","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1471-4159.2002.00947.x","article-title":"Stimulation of 5-hydroxytryptamine (5-HT 2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex","volume":"82","author":"Pozzi","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(25)22843-9","article-title":"Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo","volume":"271","author":"Prisco","year":"1994","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biocel.2024.106669_bib80","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2023.14530","article-title":"Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial","volume":"330","author":"Raison","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.biocel.2024.106669_bib81","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0006-8993(86)91090-5","article-title":"Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists","volume":"385","author":"Rasmussen","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuropharm.2015.10.016","article-title":"The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT 1A and 5-HT 2A receptors","volume":"101","author":"Riga","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib83","series-title":"Life Sciences","article-title":"Response of central monoaminergic neurons to lisuride: comparison with LSD","author":"Rogawski","year":"1979"},{"key":"10.1016\/j.biocel.2024.106669_bib84","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1523\/JNEUROSCI.01-10-01148.1981","article-title":"Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs","volume":"1","author":"Rogawski","year":"1981","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib85","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1248\/bpb.b14-00315","article-title":"Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats","volume":"38","author":"Sakashita","year":"2015","journal-title":"Biol. ^|^ Pharm. Bull."},{"key":"10.1016\/j.biocel.2024.106669_bib86","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjp.0703139","article-title":"Postsynaptic 5-hydroxytryptamine 1A receptor activation increases in vivo dopamine release in rat prefrontal cortex","volume":"129","author":"Sakaue","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106677","article-title":"Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice","volume":"175","author":"Saraf","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biocel.2024.106669_bib88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0014-2999(92)90819-P","article-title":"5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine","volume":"223","author":"Schmidt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib89","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41591-023-02378-5","article-title":"Psychedelic treatments for mental health conditions pose challenges for informed consent","volume":"29","author":"Seybert","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.biocel.2024.106669_bib90","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)10609-5","article-title":"Ritanserin, a 5-HT2A\/2C antagonist, reverses direct dopamine agonist-induced inhibition of midbrain dopamine neurons","volume":"274","author":"Shi","year":"1995","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biocel.2024.106669_bib91","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0022-3565(25)38366-7","article-title":"Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies","volume":"266","author":"Sorensen","year":"1993","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biocel.2024.106669_bib92","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1471-4159.1985.tb04092.x","article-title":"Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact","volume":"45","author":"Spampinato","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biocel.2024.106669_bib93","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1476-5381.1969.tb07983.x","article-title":"A study of the role of noradrenaline in behavioural changes produced in the rat by psychotomimetic drugs","volume":"35","author":"Sugrue","year":"1969","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(81)90507-2","article-title":"Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats","volume":"215","author":"Trulson","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib95","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/0024-3205(79)90078-X","article-title":"Alterations of serotonin and LSD receptor binding following repeated administration of LSD","volume":"24","author":"Trulson","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.biocel.2024.106669_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.665739","article-title":"Microglia function on precursor cells in the adult hippocampus and their responsiveness to serotonin signaling","volume":"9","author":"Turkin","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biocel.2024.106669_bib97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2014a pet study with [11C]raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biocel.2024.106669_bib98","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.biocel.2024.106669_bib99","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(00)00935-3","article-title":"Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum","volume":"412","author":"Westerink","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biocel.2024.106669_bib100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(97)01267-5","article-title":"Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens","volume":"781","author":"Willins","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.biocel.2024.106669_bib101","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms25010100","article-title":"Limbic system response to psilocybin and ketamine administration in rats: a neurochemical and behavioral study","volume":"25","author":"Wojtas","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.biocel.2024.106669_bib102","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.40.4.228","article-title":"A biochemical and pharmacological suggestion about certain mental disorders","volume":"40","author":"Woolley","year":"1954","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biocel.2024.106669_bib103","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnmol.2019.00136","article-title":"Astrocyte, a promising target for mood disorder interventions","volume":"12","author":"Zhou","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.biocel.2024.106669_bib104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tiv.2017.05.010","article-title":"Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay","volume":"45","author":"Zwartsen","year":"2017","journal-title":"Toxicol. Vitr."}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272524001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272524001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:43:17Z","timestamp":1778600597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272524001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":104,"alternative-id":["S1357272524001614"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2024.106669","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classical psychedelics\u2019 action on brain monoaminergic systems","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2024.106669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106669"}}